Watch: New Cancer Drugs from Artificial Life

In 2014 artificial life was made for the first time.

Two new nucleotides were added—X and Y—to the standard four: A, G, T, C

These new nucleotides allow for the addition of unnatural amino acids to create entirely new kinds of proteins.

Now biotech company Synthorx has announced that they have developed a new cancer drug using these artificial bacteria.

Interleukin-2 has been studied for decades as an immune system-stimulating cancer therapy, but it unfortunately comes with some serious side effects and is often unpredictable.

By adding an extra unnatural amino acid to Interleukin, Synthorx created a “Synthorin” that prolongs the protein’s activity while eliminating its immune-suppressing effects.

So, it turns out that creating artificial life is more than a cool laboratory trick—it may turn out to be a great new way to create new drugs as well.

http://www.sandiegouniontribune.com/business/biotech/sd-me-synthorx-cancer-20180430-story.html

Follow us on social media for the latest updates in B2B!

Image

Latest

technology
Clarity Under Pressure: Technology, Trust, and the Future of Public Safety
February 7, 2026

When something goes wrong in a community—a major storm, a large-scale accident, a violent incident—there’s often a narrow window where clarity matters most. Leaders must make fast decisions, responders need to trust the information in front of them, and the systems supporting those choices have to work as intended. Public safety agencies now rely…

Read More
weather Intelligence
Clarity in the Storm: Weather Intelligence, GIS, and the Future of Operational Awareness
February 6, 2026

For many organizations today, weather has shifted from an occasional disruption to a constant planning factor. Scientific assessments show that extreme weather events—including heatwaves, heavy rainfall, and wildfires—are occurring more frequently and with greater intensity, placing growing strain on infrastructure, utilities, and public services. As weather-related disruptions become more costly and harder to manage,…

Read More
AI in sterile processing
AI in Sterile Processing Is Proving Its Value by Acting as a Co-Pilot, Not a Replacement
February 5, 2026

Sterile processing departments are dealing with persistent operational pressures. Surgical case volumes are rising, instruments are more complex, and staffing shortages remain across many health systems. Accuracy and documentation requirements continue to tighten, leaving little room for error. In busy hospitals, sterile processing teams may handle 10,000 to 30,000 surgical instruments per day, with…

Read More
IC-SAT100
Meet IC-SAT100, a Satellite PTT Radio Built for the World’s Most Demanding Environments
February 5, 2026

Let’s have a look at Icom’s IC-SAT100, a satellite Push-To-Talk radio designed for moments when ordinary communication just isn’t an option. Powered by the Iridium satellite network, this rugged handheld delivers instant one-to-many communication at the push of a button—no cell towers or ground infrastructure required. Built to thrive in harsh environments, it’s waterproof,…

Read More